COVID-19 and renal allograft rejection: insight from controlled and non-controlled studies
View abstract on PubMed
Summary
This summary is machine-generated.COVID-19 infection does not significantly increase the risk of kidney transplant rejection, according to limited controlled studies. However, non-controlled studies indicate a variable rejection rate in kidney transplant recipients (KTRs).
Area Of Science
- Nephrology
- Virology
- Immunology
Background
- Kidney transplant recipients (KTRs) are immunocompromised, increasing vulnerability to severe COVID-19 and organ complications.
- Assessing the impact of COVID-19 on transplanted organs is crucial for patient management.
Purpose Of The Study
- To investigate the association between COVID-19 infection and the risk of rejection in kidney transplant recipients.
- To analyze existing literature for evidence linking SARS-CoV-2 to kidney allograft rejection.
Main Methods
- A comprehensive literature review was conducted using PubMed, with searches completed by September 7th, 2023.
- Keywords included 'COVID', 'Renal', 'Kidney', 'Transplant', and 'Rejection'.
- Data from controlled and uncontrolled studies were analyzed separately.
Main Results
- Eleven studies involving 1,179 patients were identified.
- Two controlled studies found no statistically significant link between COVID-19 and biopsy-proven rejection (p=0.26).
- Nine non-controlled studies reported a pooled rejection rate of 11.8%, with wide individual study variations (0%-66.7%).
Conclusions
- Limited controlled studies suggest no significant association between COVID-19 and kidney transplant rejection.
- Non-controlled studies indicate a notable, albeit variable, rejection incidence.
- Further high-quality research is needed to definitively establish the relationship between COVID-19 and KTR rejection.
Related Concept Videos
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Overview
The cell-mediated immune system is the host’s primary response against invasive bacteria and viruses that cause intracellular infections. It is also essential for fighting against and destroying cancer cells. Furthermore, the cell-mediated immune system plays a role in the rejection of organ transplants or graft tissue.
The Innate Immune System Activates the Adaptive Immune System
Phagocytic cells of the innate immune system, such as macrophages or dendritic cells, are the...
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

